Pancreatic Cancer Research

ResearcherUniversity of MichiganActive in the last 2 years

Hari Nathan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7402-2403; OpenAlex author ID A5103101943. Sources: OpenAlex.

Their work

Papers
12 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
50
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 2 papers · 2020: 2 papers · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper

Papers 12

  1. A Comparison of Spatial and Phenotypic Immune Profiles of Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions. Co-author DOI 10.3390/ijms25052953↗
  2. Immunotherapy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/jso.26312↗
  3. Association of Adjuvant Radiotherapy With Survival After Margin-negative Resection of Pancreatic Ductal Adenocarcinoma: A Propensity-matched National Cancer Da… Last author DOI 10.1097/sla.0000000000003242↗
  4. Phase 2 Trial of Neoadjuvant FOLFIRINOX and Intensity Modulated Radiation Therapy Concurrent With Fixed-Dose Rate-Gemcitabine in Patients With Borderline Resec… Co-author DOI 10.1016/j.ijrobp.2019.08.057↗
  5. Multimodal Mapping of the Tumor and Peripheral Blood Immune Landscape in Human Pancreatic Cancer. Co-author DOI 10.1038/s43018-020-00121-4↗
  6. Regional and racial variations in the utilization of endoscopic retrograde cholangiopancreatography among pancreatic cancer patients in the United States. Co-author DOI 10.1002/cam4.2225↗
  7. Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic C… Co-author DOI 10.1200/jco.19.00730↗
  8. Tracking Macrophage Infiltration in a Mouse Model of Pancreatic Cancer with the Positron Emission Tomography Tracer [11C]PBR28. Co-author DOI 10.1016/j.jss.2018.07.015↗
  9. Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiolo… Last author DOI 10.1245/s10434-017-5810-x↗
  10. A Pilot Study Evaluating Serum MMP7 as a Preoperative Prognostic Marker for Pancreatic Ductal Adenocarcinoma Patients. Co-author DOI 10.1007/s11605-015-3057-z↗
  11. Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent. First author DOI 10.1002/cncr.26553↗
  12. Management of patients with pancreatic adenocarcinoma: national trends in patient selection, operative management, and use of adjuvant therapy. Co-author DOI 10.1016/j.jamcollsurg.2011.09.022↗

Closest collaborators

The 25 strongest of 50 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Timothy L. Frankel · 6 shared papers, 2017–2024 · strength 0.76
  2. Vaibhav Sahai · 5 shared papers, 2019–2024 · strength 0.62
  3. Clifford S. Cho · 4 shared papers, 2017–2021 · strength 0.42
  4. Filip Bednar · 3 shared papers, 2020–2021 · strength 0.36
  5. Theodore Steven Lawrence · 3 shared papers, 2019–2021 · strength 0.33
  6. Jiaqi Shi · 2 shared papers, 2020–2024 · strength 0.33
  7. Marina Pasca di Magliano · 3 shared papers, 2018–2021 · strength 0.30
  8. Sivesh Kathir Kamarajah · 2 shared papers, 2017–2021 · strength 0.24
  9. Brian D. Griffith · 1 shared paper, 2024 · strength 0.23
  10. Thomas Enzler · 1 shared paper, 2024 · strength 0.23
  11. Clifford Cho · 2 shared papers, 2020–2021 · strength 0.21
  12. Eileen S. Carpenter · 2 shared papers, 2020–2021 · strength 0.21
  13. Mark M. Zalupski · 2 shared papers, 2019–2020 · strength 0.19
  14. Kyle Clifford Cuneo · 2 shared papers, 2019–2020 · strength 0.19
  15. Nguyen H. Tran · 1 shared paper, 2020 · strength 0.10
  16. Edward Jae-Hoon Kim · 1 shared paper, 2020 · strength 0.10
  17. Ravi Kiran Kaza · 1 shared paper, 2020 · strength 0.10
  18. William R. Burns · 1 shared paper, 2017 · strength 0.09
  19. Mirna Perusina Lanfranca · 1 shared paper, 2018 · strength 0.09
  20. Leslie A. Parsels · 1 shared paper, 2019 · strength 0.08
  21. Jonathan Maybaum · 1 shared paper, 2019 · strength 0.08
  22. Meredith Ann Morgan · 1 shared paper, 2019 · strength 0.08
  23. James M. Scheiman · 1 shared paper, 2019 · strength 0.08
  24. Caitlin C. Murphy · 1 shared paper, 2019 · strength 0.08
  25. Anna Tavakkoli · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.